Skip to main content
. 2021 Mar 29;60(17):2831–2837. doi: 10.2169/internalmedicine.6470-20

Figure 7.

Figure 7.

Chest CT findings before osimertinib treatment (A). The infiltrative shadow in the right lower lobe is dramatically reduced, indicating an antitumor effect two months after starting osimertinib (B).